在抗凝剂治疗中管理出血:临床医生的实用指南
Mattia Galli1,2, Beatrice Simeone1, Jurrien Ten Berg3
1Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina 04100, Italy.
European heart journal. Acute cardiovascular care
|March 12, 2026
概括
口服抗凝剂可以防止血栓形成,但会增加出血风险. 本综述提供了关于管理出血和安全恢复抗凝血药物的指导,以获得更好的患者结果.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 流血是口服抗凝剂治疗的常见和严重并发症.
- 患有心房等疾病的患者面临出血风险增加,影响发病率和死亡率.
- 在出血后停止服用抗凝剂可能会导致随后的缺血事件.
研究的目的:
- 审查口服抗凝剂患者出血的流行病学和临床影响.
- 为管理急性出血和恢复抗凝药提供以患者为中心的流程图.
- 突出未来研究领域,以优化抗凝剂治疗和患者安全.
主要方法:
- 文献综述侧重于口服抗凝剂治疗中的出血并发症.
- 综合流行病学数据和临床影响评估.
- 开发基于证据的管理和恢复治疗的流程图.
主要成果:
- 口服抗凝剂虽然对预防血栓事件至关重要,但显著增加出血风险.
- 出血事件具有长期后果,包括对治疗坚持和未来缺血事件风险的影响.
- 有效管理需要通过分层,预防和及时干预来平衡血栓和出血风险.
结论:
- 优化预防血栓形成和控制出血之间的平衡对于服用口服抗凝剂的患者至关重要.
- 当代的管理策略和明确的指导方针对于恢复抗凝血是必不可少的.
- 未来的研究应该优先考虑改进风险预测,个性化疗法和可访问的逆转剂.
相关概念视频
Venous Thrombosis IV: Nursing Management
352
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
352
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Venous Thrombosis III: Interprofessional Care
449
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
449
Esophageal Varices-II: Clinical Features and Management
723
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
723
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.6K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K
Disorders of Hemostasis
2.6K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.6K


